Press "esc" to clear
Go to Advanced Search

Showing results

110 of 5594
Embargo will expire:
10-Dec-2018 11:00 AM EST
Released to reporters:
9-Dec-2018 11:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 705143

Nearly $1 million NSF grant to bolster cyber-physical systems security

Missouri University of Science and Technology

A team of Missouri University of Science and Technology researchers has received a National Science Foundation research grant of nearly $1 million to develop stronger safeguards for a wide array of complex systems that rely on computers – from public water supply systems and electric grids to chemical plants and self-driving vehicles.

Released:
7-Dec-2018 5:05 PM EST
breastcancerbiosensorimage.jpg

Article ID: 705138

Using inkjet printers to build a new biosensor for less invasive breast cancer detection

National Institute of Biomedical Imaging and Bioengineering

NIBIB-funded researchers have created a novel, low-cost biosensor to detect HER-2, a breast cancer biomarker in the blood, allowing for a far less invasive diagnostic test than the current practice, a needle biopsy. Scientists at the Universities of Hartford and Connecticut and funded in part by NIBIB, combined microfluidic technology with diagnostics, including electrochemical sensors and biomarkers, into a powerful package that can give results in about 15 minutes.

Released:
7-Dec-2018 2:05 PM EST
Embargo will expire:
10-Dec-2018 2:00 PM EST
Released to reporters:
7-Dec-2018 1:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 705116

Opioid Prescriptions Can Be Drastically Reduced After Surgery with No Increase in Pain, Study Shows Striking

Roswell Park Comprehensive Cancer Center

Pain after surgery can be effectively managed with minimal or no opioids, according to research conducted at Roswell Park Comprehensive Cancer Center and published today in JAMA Network Open. A two-year study by a multidisciplinary team of surgeons and other cancer specialists shows that the amount of opioid medications prescribed after surgery can be drastically reduced without negatively affecting pain scores, postoperative complications or patient requests for additional

Released:
7-Dec-2018 11:05 AM EST
180226_RCC_Abstract-Dec2_d1A.jpg
  • Embargo expired:
    7-Dec-2018 11:00 AM EST

Article ID: 704892

Some people uncomfortable discontinuing colorectal cancer screening even when benefit is low

Michigan Medicine - University of Michigan

A new study finds 29 percent of veterans who underwent recommended screening colonoscopies were uncomfortable with the idea of stopping these screenings when the benefit was expected to be low for them personally.

Released:
4-Dec-2018 1:05 PM EST
Embargo will expire:
10-Dec-2018 3:00 PM EST
Released to reporters:
6-Dec-2018 6:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 3:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

winzler_researchteam_UCSDHealth.jpg
  • Embargo expired:
    6-Dec-2018 2:00 PM EST

Article ID: 704793

One Million Mosquitoes and 500,000 Tests Later, New Buzz about a Malaria Prevention Drug

University of California San Diego Health

Researchers spent two years testing chemical compounds for their ability to inhibit the malaria parasite at an earlier stage in its lifecycle than most current drugs, revealing a new set of chemical starting points for the first drugs to prevent malaria instead of just treating the symptoms.

Released:
3-Dec-2018 1:05 PM EST
12-6-2018RaiganParikRelease.png

Article ID: 705054

Medical Records Study Suggests Kidneys from Deceased Donors with Acute Kidney Injury are Suitable for Transplant

Johns Hopkins Medicine

In medical chart reviews of 2,430 kidneys transplanted from 1,298 donors—585 (24 percent) of them with AKI—researchers say they found no significant differences in rates of organ rejection among kidneys from deceased donors with or without AKI. They also report they found no evidence that factors such as the amount of time an organ is chilled and left without blood supply before transplantation had any impact on recipient outcomes for those who received AKI kidneys.

Released:
6-Dec-2018 1:00 PM EST
Embargo will expire:
11-Dec-2018 11:00 AM EST
Released to reporters:
6-Dec-2018 12:00 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 11-Dec-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 5594

Chat now!